La Jolla Pharmaceutical Company · San Diego, CA United States (Pink Sheets: LJPC)
| 6455 Nancy Ridge Dr. | Phone: 858-452-6600 |
| San Diego, CA | Fax: 858-626-2851 |
| 92121 | |
| United States | 
Map This Company |
La Jolla Pharmaceutical Company Rankings
More Companies in These Related Industries: Pharmaceutical Preparation MfgCompany Description
La Jolla Pharmaceutical aims to eliminate tissue damage. The company is working to develop tissue-repair compounds based on a cell-stimulating regenerative medicine technology. It is focused on skin and lung tissue, cardiac muscle, cartilage, and bone repair. La Jolla Pharmaceutical had previously ceased most of its operations after trials of lupus candidate Riquent failed in 2009. After exploring its options, the firm began searching for new potential pharmaceutical candidates to develop. In 2011 La Jolla found a new focus when it acquired a regenerative medicine program for tissue repair from private research firm GliaMed.
La Jolla Pharmaceutical Company Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - Pink Sheets: LJPC Single Location |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 3 |
Executives
13 executives listed for La Jolla Pharmaceutical Company's San Diego, CA location.
| Chairman | Craig Smith | |
|---|---|---|
| President, CEO, and Director | Deirdre Gillespie | |
| VP Finance and Secretary | Gail Sloan |